ANVS Annovis Bio Inc

Price (delayed)

$13.6

Market cap

$149.75M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.23

Enterprise value

$144M

Headquartered in Berwyn, Pennsylvania, Annovis Bio, Inc. (Annovis) is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease (AD), Parkinson's disease (PD) and Alzheimer's in Down Syndrome (AD-DS). ...

Highlights

ANVS's equity has dropped by 127% year-on-year

The net income has dropped by 122% year-on-year and by 35% since the previous quarter

Sector: Healthcare

Industry: Biotechnology

Website: http://www.annovisbio.com

Peers: ANET DBD ITRI

Key stats

What are the main financial stats of ANVS

Market

Shares outstanding

11.01M

Market cap

$149.75M

Enterprise value

$144M

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

N/A

Price to sales (P/S)

N/A

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

N/A

Earnings

Revenue

EBIT

-$56.2M

EBITDA

-$56.2M

Free cash flow

-$39.97M

Per share

EPS

-$6.23

Free cash flow per share

-$4.43

Book value per share

-$0.76

Revenue per share

TBVPS

$1.13

Balance sheet

Total assets

$10.21M

Total liabilities

$17.96M

Debt

Equity

-$7.75M

Working capital

$5.93M

Liquidity

Debt to equity

Current ratio

2.39

Quick ratio

1.34

Net debt/EBITDA

0.1

Margins

EBITDA margin

N/A

Gross margin

N/A

Net margin

N/A

Operating margin

N/A

Efficiency

Return on assets

-326.8%

Return on equity

-565.1%

Return on invested capital

-2,533.7%

Return on capital employed

-947.9%

Return on sales

N/A

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

ANVS stock price

How has the Annovis Bio stock price performed over time

Intraday

6.75%

1 week

38.07%

1 month

14.29%

1 year

-7.92%

YTD

-27.27%

QTD

14.29%

Financial performance

How have Annovis Bio's revenue and profit performed over time

Revenue

Gross profit

Operating income

-$45.04M

Net income

-$56.2M

Gross margin

N/A

Net margin

N/A

The net income has dropped by 122% year-on-year and by 35% since the previous quarter

The company's operating income has shrunk by 77% YoY and by 6% QoQ

Growth

What is Annovis Bio's growth rate over time

Valuation

What is Annovis Bio stock price valuation

P/E

N/A

P/B

N/A

P/S

N/A

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

N/A

The EPS has dropped by 101% year-on-year and by 29% since the previous quarter

ANVS's equity has dropped by 127% year-on-year

Efficiency

How efficient is Annovis Bio business performance

The company's return on equity has shrunk by 157% QoQ

The return on assets has dropped by 85% since the previous quarter

ANVS's ROIC is down by 31% QoQ

Dividends

What is ANVS's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for ANVS.

Financial health

How did Annovis Bio financials performed over time

Annovis Bio's total assets is 43% lower than its total liabilities

ANVS's total liabilities has soared by 133% YoY

Annovis Bio's total assets has shrunk by 72% YoY

The company's debt is 100% higher than its equity

ANVS's equity has dropped by 127% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.